The effect of use of human blood derived platelet concentrate material for better adaptation of gums (gingiva) over exposed root surface of the tooth among people having receeding gums.

Efficacy of injectable platelet rich fibrin (iPRF) as a root biomodification agent in the management of RTI gingival recession- a double blinded randomised control trial. - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065688

Enrollment

Registered

2024-04-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K055- Other periodontal diseases

Interventions

Intervention1: Coronally advanced flap + iPRF: Coronally advanced flap with iPRF as a root biomodification agent done at the time of surgical procedure and evaluation done at baseline and 6months. To

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients with RT l gingival recession. 2 teeth with visible cementoenamel junction 3 subjects were at least 20 years old 4 participants who are periodontally healthy 5 General health status - ASA I and ASA II

Exclusion criteria

Exclusion criteria: 1 Smokers 2 subjects with cervical caries 3 probing depth more than 4mm

Design outcomes

Primary

Measure	Time frame
Probing depth, Clinical attachment level, Keratinised tissue gain, Gingival thickness, Recession width, Recession height, Mean root coverage Timepoint: Baseline 6months	—

Secondary

Measure	Time frame
Pink esthetic scoreTimepoint: Baseline and 6months	—

Countries

India

Contacts

Public ContactDr Sankari Malaiappan

Saveetha dental college and hospital, SIMATS University, Chennai

152205003.sdc@saveetha.com9600177122

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026